A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
| Status: | Completed |
|---|---|
| Conditions: | Hospital, Neurology |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | December 2007 |
| End Date: | April 2009 |
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
The purpose of this study is to evaluate efficacy and safety of treatment with XP19986
Sustained Release (SR) Tablet compared to placebo in subjects with spasticity due to spinal
cord injury
Sustained Release (SR) Tablet compared to placebo in subjects with spasticity due to spinal
cord injury
Inclusion Criteria:
- Spasticity secondary to traumatic spinal cord injury between C-5 and T-12 spinal cord
levels, at least 12 months post-injury with a stable neurological deficit
Exclusion Criteria:
- Traumatic brain injury or cognitive deficit of any etiology that may influence
compliance with study procedures or outcome measures
We found this trial at
11
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials